Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
Sign Up to like & getrecommendations! Published in 2017 at "Osteoporosis International"
DOI: 10.1007/s00198-017-3940-4
Abstract: SummaryWe constructed a Markov microsimulation model among hypothetical cohorts of community-dwelling elderly osteoporotic Japanese women without prior hip or vertebral fractures over a lifetime horizon. Compared with weekly oral alendronate for 5 years, denosumab every 6 months… read more here.
Keywords: alendronate; denosumab; elderly osteoporotic; cost effectiveness ... See more keywords